Alexis Weymann Perlmutter, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2508 Western Ave, Altamont, NY 12009 Phone: 518-690-0177 Fax: 518-690-0169 |
News Archive
In a small clinical study with an anticancer drug that halts blood vessel growth, a handful of people with neurofibromatosis type 2 (NF2) and hearing loss had restoration of hearing.
Most prescriptions for opioid painkillers are made by the broad swath of U.S. general practitioners, not by a limited group of specialists, according to a study by researchers at the Stanford University School of Medicine.
David H. Fater, CEO of Vicor Technologies, Inc., today announced the initial results of a study designed to analyze data from the Merte Subita en Insufficiencia Cardiaca Trial using its PD2i- algorithm and software. Vicor Technologies is a biotechnology company focused on the development of innovative, non-invasive medical devices using its patented, proprietary PD2i- nonlinear algorithm and software.
The U.S. Food and Drug Administration today approved TOBI Podhaler (tobramycin inhalation powder) for the management of cystic fibrosis patients with Pseudomonas aeruginosa, a bacterium that causes lung infections.
Omission Brewing Company today announced support for the FDA's new gluten-free labeling standard as an important step forward in providing clear, consistent guidance to gluten sensitive consumers, including celiac disease sufferers. With the new labeling rules issued today, the FDA has officially adopted the widely accepted standard of 20 ppm gluten, which has been in place in many countries around the world for several years.
› Verified 5 days ago